Predictive Oncology
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $611 | $345 | $278 | $419 |
Gross Profit | 320 | 148 | -38 | 69 |
EBITDA | -1,550 | -2,313 | -3,025 | -4,074 |
EBIT | -2,123 | -2,283 | -3,189 | -4,236 |
Net Income | -2,169 | -3,094 | -3,181 | -4,218 |
Net Change In Cash | 611 | 345 | 278 | 419 |
Free Cash Flow | -2,060 | -2,279 | -3,224 | -3,419 |
Cash | 734 | 3,078 | 5,331 | 5,197 |
Basic Shares | 6,667 | 6,396 | 4,664 | 4,062 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $1,623 | $1,780 | $1,505 | $1,420 |
Gross Profit | 797 | 1,145 | 1,000 | 933 |
EBITDA | -10,860 | -13,182 | -13,954 | -12,131 |
EBIT | -10,939 | -13,921 | -15,267 | -13,471 |
Net Income | -12,664 | -13,983 | -36,207 | -19,657 |
Net Change In Cash | 1,623 | 1,780 | 1,505 | 1,420 |
Free Cash Flow | -10,984 | -13,491 | -12,846 | -13,171 |
Cash | 734 | 8,728 | 22,071 | 28,202 |
Basic Shares | 5,453 | 4,014 | 3,649 | 2,743 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-03-31 | -$0.32 |
2024-12-31 | -$0.24 |
2024-09-30 | -$0.48 |
2024-06-30 | -$0.68 |
